163 related articles for article (PubMed ID: 29895648)
1. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
Balasubramanian A; Kulasingam SL; Baer A; Hughes JP; Myers ER; Mao C; Kiviat NB; Koutsky LA
J Low Genit Tract Dis; 2010 Jul; 14(3):185-95. PubMed ID: 20592553
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study.
Zhao XL; Zhao S; Xia CF; Hu SY; Duan XZ; Liu ZH; Wang YY; You TT; Gao M; Qiao YL; Basu P; Zhao FH
BMC Med; 2023 Apr; 21(1):149. PubMed ID: 37069602
[TBL] [Abstract][Full Text] [Related]
4. Cancer of the cervix: Early detection and cost-effective solutions.
Denny L; Prendiville W
Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 1():S28-32. PubMed ID: 26433500
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study.
Campos NG; Lince-Deroche N; Chibwesha CJ; Firnhaber C; Smith JS; Michelow P; Meyer-Rath G; Jamieson L; Jordaan S; Sharma M; Regan C; Sy S; Liu G; Tsu V; Jeronimo J; Kim JJ
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):195-205. PubMed ID: 29916959
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
Kositamongkol C; Kanchanasurakit S; Mepramoon E; Talungchit P; Chaopotong P; Kengkla K; Chaisathaphol T; Saokaew S; Phisalprapa P
BMC Public Health; 2023 Dec; 23(1):2413. PubMed ID: 38049773
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
Fogelberg S; Clements MS; Pedersen K; Sy S; Sparén P; Kim JJ; Burger EA
PLoS One; 2020; 15(9):e0239611. PubMed ID: 32997696
[TBL] [Abstract][Full Text] [Related]
8. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
9. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
[TBL] [Abstract][Full Text] [Related]
10. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
[TBL] [Abstract][Full Text] [Related]
11. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
[No Abstract] [Full Text] [Related]
12. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
[TBL] [Abstract][Full Text] [Related]
13. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
Teng FF; Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JK; Steinberg M; Money DM; Ogilvie GS
BMJ Open; 2014 Apr; 4(4):e004783. PubMed ID: 24727360
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
15. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
[TBL] [Abstract][Full Text] [Related]
16. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
Simms KT; Keane A; Nguyen DTN; Caruana M; Hall MT; Lui G; Gauvreau C; Demke O; Arbyn M; Basu P; Wentzensen N; Lauby-Secretan B; Ilbawi A; Hutubessy R; Almonte M; De Sanjosé S; Kelly H; Dalal S; Eckert LO; Santesso N; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3050-3058. PubMed ID: 38087115
[TBL] [Abstract][Full Text] [Related]
17. Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
Lee F; Bula A; Chapola J; Mapanje C; Phiri B; Kamtuwange N; Tsidya M; Tang J; Chinula L
BMC Cancer; 2021 Apr; 21(1):428. PubMed ID: 33882885
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Human Papillomavirus Self-collection Intervention on Cervical Cancer Screening Uptake among Underscreened U.S. Persons with a Cervix.
Spees LP; Biddell CB; Smith JS; Des Marais AC; Hudgens MG; Sanusi B; Jackson S; Brewer NT; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1097-1106. PubMed ID: 37204419
[TBL] [Abstract][Full Text] [Related]
19. Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2.
Ajenifuja KO; Belinson J; Goldstein A; Desai KT; de Sanjose S; Schiffman M
Infect Agent Cancer; 2020; 15():61. PubMed ID: 33072179
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina.
Arrossi S; Paolino M; Thouyaret L; Laudi R; Campanera A
Implement Sci; 2017 Feb; 12(1):17. PubMed ID: 28193227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
